biopharma manufacturing
biopharma manufacturing
Data Crisis Stalls Biopharma Innovation: Here’s Why!
🌐 A data crisis in biopharma is hindering CMC processes, forcing companies to prioritize cleaning over innovation. 🚀 Embrace advanced platforms! 📈
Revolutionizing Antibody Manufacturing: Simtra and MilliporeSigma Team Up!
🚀 Simtra BioPharma Solutions and MilliporeSigma join forces! 💊 Their partnership enhances antibody drug conjugate manufacturing for better patient access. 🤝✨
Revolutionary mRNA Purification Method Reshapes Industry!
Unlocking mRNA potential! 🌟 MIT's new purification method boosts efficiency and flexibility in large-scale manufacturing. 💡 Discover the future! 🔍
Eco-Friendly Surfactants Outperform TX-100 for Biopharma!
Discover eco-friendly surfactants as alternatives to Triton X-100! 🌿 Research shows promise in viral inactivation. 🦠 Stay tuned for more!
AstraZeneca Unveils $300M Game-Changer for Cell Therapy
AstraZeneca's new $300M plant in Rockville enhances CAR T therapy production, ensuring high-quality, patient-specific treatments! 🌟🏭💡🔍 CellTherapy
Streamline Bioprocesses for Big Pharma Success!
🌱 Simplifying bioprocesses boosts efficiency! Focus on essential measurements, standardization, and user-friendly designs for successful biopharma ventures. 💡🔍
Revolutionary Technique Cuts Costs in Gene Therapy!
Unlocking gene therapy's potential! 🌟 Mass photometry simplifies production by identifying viral vectors efficiently—no purification needed! 🚀💡 Innovation
Revolutionary Artificial Platelet Breakthrough for Medicine!
🌟 Breakthrough in biotechnology! PL BioScience produces artificial human platelet lysate for cell culture, supporting regenerative medicine and biopharma. 🤝💡🔬
Unlock Your Future: AI Skills for Biopharma Engineers!
Unlock your future in biopharma! 🤖 Gain essential AI and automation skills 🌍 for a thriving career in life sciences! 📚✨
Roche’s $50B US Boost: Jobs and Growth Ahead!
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
